Third-Party Payers and Investigational Therapy

Thomas C. Chalmers, Kapil Bhalla, Martin Birkhofer, Jose Lutzky, Frank E. Samuel, Peter A. Ubel

Research output: Contribution to journalLetterpeer-review

Abstract

To the Editor: Hail to Antman et al. (July 7 issue)* for highlighting in print the pernicious and shortsighted attempt of third-party insurers to reduce the cost of medical care by a method that will surely increase the overall cost in the long run. Refusing to pay for care when the patient volunteers to participate in a clinical trial is bound to decrease the amount of protocol-based, peer-reviewed research. Instead, the third parties should refuse to pay for so-called innovative practice that is not part of a well-designed clinical trial. A policy of paying for good research and not for.

Original languageEnglish (US)
Pages (from-to)1228
Number of pages1
JournalNew England Journal of Medicine
Volume319
Issue number18
DOIs
StatePublished - Nov 3 1988
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Third-Party Payers and Investigational Therapy'. Together they form a unique fingerprint.

Cite this